Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) - Related Studies

Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)

This study is currently recruiting participants.

Study NCT00617981. Last updated on November 25, 2008. Information provided by Celsion

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Hepatocellular Carcinoma

2	Additional conditions recognized in this trial
		Carcinoma
		Carcinoma, Hepatocellular
		Liver Neoplasms

3	More general conditions related to this trial
		Adenocarcinoma
		Digestive System Diseases
		Digestive System Neoplasms
		Liver Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial

4	Interventions listed in this trial
		ThermoDox
		5% Dextrose Solution

5	Additional drug interventions recognized in this trial
		Doxorubicin

6	More general drug interventions related to this trial
		Antibiotics, Antineoplastic
		Antineoplastic Agents
		Pharmacologic Actions
		Therapeutic Uses

7	Sponsors listed in this trial
		Celsion